JPRN-UMIN000014297已完成未知
The randomized controlled trial on the efficacy of cognitive behavior therapy for insomnia - Cognitive behavior therapy for insomnia
Department of Psychophysiology, National Institute of Mental Health, National Center of Neurology & Psychiatry0 个研究点目标入组 60 人开始时间: 2014年6月18日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Insomnia that occurs only in the course of other psychiatric disorders (major depressive disorder, schizophrenia cases) 2. Insomnia due to the direct physiological effects of a general medical condition or substance (drug of abuse, medication example) 3. Insomnia that occurs only during the course of other sleep disorders sleep apnea syndrome, restless legs syndrome, circadian rhythm sleep disorders, etc.
研究者
相似试验
已完成
不适用
The randomized controlled trial on the efficacy of mobile-app delivered cognitive behavioral therapy for insomniaInsomniaJPRN-UMIN000023999europsychiatric Research Institute40
已完成
3 期
The randomized controlled trial of the efficacy of goshajinkigan, mecobalamin and lafutidine in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010969Department of breast and endocrine surgery, Meiwa Hospital50
已完成
3 期
The randomized controlled trial of the efficacy of goshajinkigan and lafutidine after mecobalamin administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010988Department of breast and endocrine surgery, Meiwa Hospital35
已完成
3 期
The randomized controlled trial of the efficacy of mecobalamin and lafutidine after goshajinkigan administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000011007Department of breast and endocrine surgery, Meiwa Hospital35
尚未招募
1 期
A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19)ITMCTR2000003033Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,